Stay updated with breaking news from Paul buckler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peter Horby couldn’t believe his eyes. He’d just gotten his first glimpse of new data from the United Kingdom’s Recovery Trial, an experiment enrolling tens of thousands of patients at dozens of hospitals for clinical trials investigating Covid-19 therapies. Horby and his Oxford University colleague Martin Landray had dreamed up the trial program in March 2020. Nearly three months later, more than 35,000 people were dead in the UK (and more than 100,000 in the US), and Horby and Landray were still hunting for the world’s first lifesaving treatment for the novel coronavirus. Now Horby was looking at the results of a Recovery Trial project testing dexamethasone, a cheap, widely available steroid. It found dexamethasone had lowered the likelihood of death for Covid-19 patients who required oxygen or a ventilator while in the hospital. ....